MeSH term
Frequency | Condition_Probility | Animals | 11 | 0.0 |
Humans | 22 | 0.0 |
Mice | 9 | 0.0 |
Mice, Inbred C57BL | 7 | 0.0 |
TNF Receptor-Associated Factor 6 | 2 | 1.0 |
Macrophages/metabolism | 2 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 4 | 2.0 |
Receptors, Cell Surface/*metabolism | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
Cell Line | 4 | 0.0 |
Comparative Study | 3 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Female | 8 | 0.0 |
Ligands | 5 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Receptors, Cell Surface/genetics/*metabolism | 3 | 2.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Immunity, Natural/immunology | 2 | 8.0 |
Adult | 2 | 0.0 |
Cytokines/biosynthesis | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Lipopolysaccharides/pharmacology | 3 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Male | 4 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Imidazoles/pharmacology | 2 | 0.0 |
Membrane Glycoproteins/genetics/*immunology | 2 | 3.0 |
Receptors, Cell Surface/genetics/*immunology | 2 | 8.0 |
Lipopolysaccharides/metabolism/pharmacology | 2 | 11.0 |
Oligodeoxyribonucleotides/metabolism/pharmacology | 2 | 100.0 |
Poly I-C/metabolism/pharmacology | 2 | 100.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Interleukin-12/*biosynthesis | 2 | 5.0 |
Membrane Glycoproteins/*agonists/physiology | 2 | 100.0 |
Receptors, Cell Surface/*agonists/physiology | 2 | 66.0 |
*Drosophila Proteins | 2 | 0.0 |
Adjuvants, Immunologic/*pharmacology | 2 | 1.0 |
